Summit Tx Capital, L.P. Abbott Laboratories Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q2 2025
A detailed history of Summit Tx Capital, L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 38,982 shares of ABT stock, worth $5.25 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
38,982
Previous 26,790
45.51%
Holding current value
$5.25 Million
Previous $3.55 Billion
49.2%
% of portfolio
0.23%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,600Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$23.3 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10.5 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$8.09 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.62 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $236B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...